文献类型：期刊文献

英文题名：Preventing Ethical Risks in Cutting-Edge Biotech: China's Evolving Governance Model

作者：Chen, Jiajv[1];Gao, Muye[2,3];Xie, Xuekai[4]

机构：[1]Renmin Univ China, Sch Law, Beijing, Peoples R China;[2]Jinan Univ, Law Sch, Guangzhou, Peoples R China;[3]Jinan Univ, Intellectual Property Sch, Guangzhou, Peoples R China;[4]East China Univ Sci & Technol, Sch Law, Shanghai, Peoples R China

年份：2026

卷号：45

期号：1

起止页码：28

外文期刊名：BIOTECHNOLOGY LAW REPORT

收录：;Scopus(收录号：2-s2.0-105047625160);WOS:【SCI-EXPANDED(收录号:WOS:001687177600001)】；

基金：This study is supported by the Sichuan Medical Law Research Center Project (No. YF24-Q04) and the Outstanding Innovative Talents Cultivation Funded Programs 2024 of Renmin University of China.

语种：英文

外文关键词：ethics; He Jiankui; life sciences; ethical review; China

摘要：Ethics is a core issue that life sciences cannot avoid. In the past two decades, China has entered a high-speed development mode in the field of biotechnology, achieving many significant results, but also exposing a series of ethical issues. Among them, the most questioned is undoubtedly the He Jiankui gene editing incident. In fact, China has been promoting the establishment and improvement of technology ethics review, and the He Jiankui incident has rapidly accelerated this process. This article reviews the policies and regulations of the past and recent years to illustrate the establishment and improvement process of China's scientific and technological ethics review.